About 30 million babies are born each year in parts of Sub-Saharan Africa where malaria spreads. In July 2025 Swissmedic approved Coartem Baby, the first antimalarial made for newborns and infants under five kilograms. Novartis and the not-for-profit MMV developed the medicine.
Before this approval, health workers often had to use adult drugs in improvised ways and that could cause underdosing or overdosing. Experts say maternal antibodies fade within weeks, so newborns quickly become exposed. Eight African countries joined the review and promised to fast-track national approvals within 90 days.
Difficult words
- malaria — A serious disease spread by mosquitoes.malaria is
- medicine — A substance used to treat illness.medicine meant
- approved — Officially accepted or allowed.
- treatment — Care to help someone feel better.
- vulnerable — Easily harmed or hurt.
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why do you think newborns were often excluded from drug studies?
- How can new medicines help vulnerable groups in the future?
Related articles
Citizen science could help monitor health and the SDGs
A systematic review in Frontiers in Public Health finds citizen science can support monitoring many health and well‑being indicators in the UN Sustainable Development Goals and the WHO Triple Billion Targets. Authors are from IIASA and WHO.
Turning Water Hyacinth into Biodegradable Sanitary Pads
Researcher Pooja Singh and colleagues used invasive water hyacinth to make eco-friendly sanitary pads. Their project won an Elsevier award in Pune and aims to reduce water and plastic pollution while supporting women in local communities.
Teen drug use in the US stays near pandemic low
For the fifth year in a row, use of most substances among US teenagers remains close to the low point reached in 2021, according to the University of Michigan's Monitoring the Future survey. Some drugs rose slightly, and researchers say monitoring must continue.